The mother, Ms. M. Brown, noted, “I knew the pregnancy was high risk but was not aware of the true level of how serious things were until after my c-section.”
Uterine fibroids, also called leiomyomas or myomas are benign (non-cancerous) growths that develop from the muscle tissue of the uterus.
In cases of women suffering from uterine fibroids, the uterus, with the fibroid on top of it, normally resides in the lower pelvis (true pelvis). However, in the case of Mrs. Brown the growth of the fibroid resulted in her uterus being bent in a complete U-shape.
The five-hour-long surgery to rectify these complications led to Dr Sipos and his team gaining access to the fetus by conducting a cross-sected procedure to the lower part of the uterus which permitted access to the back wall at the top where the baby was positioned. The fibroid was removed to prevent this from happening again, and to reduce the blood supply the uterus needed.”
The procedure, which Dr. Irimia only found one similar case through research, not only facilitated the safe delivery of Mrs. Brown’s baby but allowed for her uterus and fertility to be preserved. Both mother and baby are doing well and are on the path to recovery.
Mrs. Brown expressed her gratitude for the treatment received at the HSA.
Dr. Sipos joined the HSA in 2019 and is Head of the Women’s Health Department and specialises in angiogenic fetal stem cells in the mother, fetus, and ovarian cancer. His experience includes being a researcher and lecturer at the universities of Manchester and Sheffield in both fetal medicine and gynaecological oncology. He also served as a visiting researcher at the universities of Cambridge and Alberta.